Delivery Order SPE2DB22D2211-SPE2DB25FRQLL

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $270 delivery order to Amerisourcebergen Drug Corporation for the supply of 4,562,195,743 levothyroxine 150 mcg capsules. The firm fixed price order is valued at two hundred seventy dollars and thirty-three cents. Performance will take place in Conshohocken, Pennsylvania from September 15 through September 18, 2023. This order was awarded under an existing DLA pharmaceutical supply vehicle and will provide the agency with thyroid medication to support its...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Levothyroxine 150 MCG tablets. The delivery order has a firm fixed price of $2,304.88 and a period of performance through March 13, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this award. It is also the prime contractor on a larger $999,999,999 indefinite delivery contract...
The Defense Logistics Agency awarded a $160,770 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561558078 levothyroxine 50 mcg capsules, 30 count. The single award delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to provide pharmaceutical products to DLA. Performance will take place in Conshohocken, Pennsylvania from July 20-21, 2023. No set aside designation or subcontractors were identified....
The Defense Logistics Agency (DLA) awarded a $5,677.51 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 500 mcg vials of the pharmaceutical drug levothyroxine. This delivery order has a completion date of February 5, 2024 and was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Levothyroxine 100 mcg vials, a pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $5,827.96 and a completion date of December 27, 2023. There is no set-aside designation associated with this contract. Amerisourcebergen Drug Corp is a prime contractor...
This federal contract award issued by the Defense Logistics Agency (DLA) is for the delivery of Levothyroxine 100 MCG Vials, a pharmaceutical product. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,797.52. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 21, 2025. The contract does not have a set-aside designation,...
The Defense Logistics Agency awarded a $11,490 delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 100 microgram Levothyroxine tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning from July 28 to July 31, 2023. Levothyroxine is a prescription medication used to treat an underactive thyroid. This delivery order was issued against an existing DLA pharmaceutical supply contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,549.20 firm fixed-price contract is for the supply of 4567115093 LEVOTHYROXINE 100 MCG VIALS, a critical pharmaceutical product, with a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of 4,563,268 units of the pharmaceutical product Levothyroxine 175 MCG Capsule 30s. The firm fixed price contract has a potential value of $13,555.90 and a completion date of January 9, 2024. No set-aside designation was used for this...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,945.20 for the supply of 4,564,085,692 units of 100 mcg/5 ml vial of levothyroxine. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and also holds an Indefinite Delivery Contract (IDC) with DLA valued at...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRQLL
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,273.31, is for the delivery of 4,567,154,037 units of Levothyroxine 150 MCG Capsule 30S, a medication used to treat hypothyroidism. The contract has a Firm Fixed Price pricing type and a completion date of February 5, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this specific contract award.

Generated 5/6/25, 11:09 AM